Page-3 of Bharat Biotech

India-Bangladesh sign MoU on COVID-19 Vaccine

On November 5, 2020, the Government of Bangladesh signed a Memorandum of Understanding with the Serum Institute of India for priority delivery of 3 crore COVID-19 vaccine doses. This COVISHIELD Vaccines was developed by AstraZeneca and University of Oxford. Highlights ..

Month: 

Phase-2 trials of Bharat Biotech vaccine to begin in September

As reported by India Today, the phase I trial for the COVID 19 vaccine made by Bharat Biotech is complete and the Phase II of this trial is going to commence in September. In the first phase of the trial, ..

Month: 

Dr. Dangs Lab to Partner with Bharat Biotech for Human Trials of Covaxin

The Delhi-based private laboratory, Dr Dangs Lab, has announced that they have been selected as the central laboratory for human clinical trials of Covaxin, which is touted as the first-ever indigenous vaccine developed by Bharat Biotech in collaboration with the ..

Month: 

India begins human trials of COVID-19 vaccines

On July 13, 2020, the AIIMS (All India Institute of Medical Sciences) Patna began human trials of COVID-19 on 10 volunteers. Highlights The first dose was given to selected 10 people though several volunteered. The second dose is to be ..

Month: 

ICMR to launch COVAXIN on August 15

On July 2, 2020, Indian Council of Medical Research announced that it is to launch COVAXIN, India’s first COVID-19 vaccine by August 15. Highlights There are 12 institutes that are conducting the clinical trials of the indigenous vaccine. Currently India ..

Month: 

Bharat Biotech’s Typbar-TCV: WHO approves Indian typhoid vaccine for global use

The World Health Organisation (WHO) has given its pre-qualification to Typbar Typhoid Conjugate Vaccine (TVC) developed by Hyderabad based Bharat Biotech for global use. Typbar TCV is world’s first typhoid vaccine clinically proven to be administered to children from six ..

Month: